Remove 2013 Remove Biosimilars Remove Insurance Coverage and Processing
article thumbnail

AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma industry

Express Pharma

On the global stage, AI and Machine Learning (ML) drove drug discovery and process optimisation, especially as large-scale pharma companies adopted AI for precision medicine. Building sophisticated laboratories, recruiting scientific talent, and collaborating with global research institutions are essential steps in this process.

article thumbnail

Top Performing Drug – Enbrel (June Edition)

PharmaShots

The co-promotion collaboration agreement between the two companies in the United States and Canada expired on October 31, 2013. Some of the alternative drugs for Enbrel include: Enbrel’s Biosimilars6 As Enbrel has a long journey in the market it is already facing competition from biosimilars in the US and other countries.